Golden
Senti Biosciences

Senti Biosciences

A synthetic biology company that designs, builds and tests genetic circuits for the purposes programming cell therapies. Their first therapeutic candidates are aimed at solid tumors and blood cancer and the company plans to move beyond oncology.

Edit ID  10501655 

Phillip Johnston
Phillip Johnston approved a suggestion from Golden's AI on 30 Apr 2019 10:45 pm
Edits made to:
Article (+18/-18 characters)

Article

Co-founder and CEO Dr. Tim Lu, (M.D.,Ph.D.) is an Associate Professor at MIT in Biological Engineering, Electrical Engineering and Computer Science and co-founder of Synlogic, Tango TherapeuticsTango Therapeutics, Sample6, Eligo BiomX and Engine Biosciences. In Fall 2018, Gary Lee, Ph.D., previously with Sangamo Therapeutics, joined Senti as Chief Scientific Officer. Senti’s Chief Financial Officer Curt Herberts also comes from Sangamo.